|
|
|
|
Institute of Cardiovascular Sciences, University of Manitoba, Faculty of Medicine, St. Boniface Research Centre, Winnipeg, Manitoba, Canada (R.B., A.O., H.D.L., P.C., M.H., L.V.H.); Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (T.M., A.B.,); Taisho Pharmaceutical Co., Ltd., Tokyo, Japan (K.T.); and UCLA Cardiovascular Research Labs, Los Angeles, California (D.A.N., K.D.P.)
Received August 25, 2003; accepted November 26, 2003
| Abstract |
|---|
|
|
|---|
3 µM (Hilgemann et al., 1992b
At low levels of regulatory Ca2+, NCX1.1 can enter into a second inactive state, referred to as Ca2+i-dependent or I2 inactivation (Hilgemann et al., 1992a
). I2 inactivation manifests mainly as changes in peak current levels and is relieved by intracellular Ca2+ with a K1/2 of
0.3 µM. Because the Ca2+i-dependent relief of I2 occurs with an approximately 10-fold higher potency than Ca2+i-dependent relief of I1, relatively small increments of cytoplasmic Ca2+ increase peak exchange current much more than the corresponding steady-state current component.
Structure-function analyses of NCX1.1 and CALX1.1, a Na+-Ca2+ exchanger from Drosophila melanogaster, have provided important information delineating the protein domains involved in I1 and I2 inactivation (Matsuoka et al., 1997
; Dyck et al., 1998
). Regulation of Na+i-dependent inactivation is thought to involve amino acids 219 to 238 of NCX1.1, the so-called XIP region, located at the N terminus of the large cytoplasmic loop of the exchanger (Matsuoka et al., 1997
). Mutations in this region have been shown to enhance or suppress I1 inactivation. Similar results have been obtained with CALX1.1 bearing mutations at the analogous positions within its amino acid sequence (Dyck et al., 1998
). A high-affinity Ca2+ binding site that modulates I2 inactivation is also located in the large intracellular loop of NCX1.1 and CALX1.1 (Levitsky et al., 1994
; Matsuoka et al., 1995
; Dyck et al., 1998
). Mutations in this region result in substantial alterations in the binding affinity of 45Ca2+ to NCX1.1 fusion proteins and in the Ca2+i-sensitivity of Na+-Ca2+ exchange currents recorded from both NCX1.1 and CALX1.1.
Until recently, there have been very few potent or selective inhibitors of cardiac sarcolemmal Na+-Ca2+ exchange. However, newer studies (Matsuda et al., 2001
; Tanaka et al., 2002
; Lee et al., 2003
) have shown that SEA0400 (SEA) inhibits NCX1.1 with high affinity (IC50
23 nM) and confers considerable protective effects against cardiovascular and cerebral ischemia. One potentially important characteristic of SEA action is that it may block Na+-Ca2+ exchange in a mode-selective manner. That is, SEA preferentially inhibits outward versus inward Na+-Ca2+ exchange currents when measured in giant excised membrane patches (Lee et al., 2003
). In light of the known involvement of I1 and I2 inactivation for these distinct transport modes and their unique dependencies on the prevailing ionic conditions (Hilgemann et al., 1992a
,b
; Matsuoka et al., 1997
), it is reasonable to speculate that SEA targets discrete transport or inactive states of the exchanger, thereby producing an apparent transport mode selectivity. Based on previous data, we have proposed that SEA stabilizes and/or modulates the transition of exchangers from the E3ni state into the I1 state, with little or no effect on I2 (Lee et al., 2003
). In this study, we have investigated the effects of SEA using mutant NCX1.1 exchangers that exhibit altered ionic regulatory properties. Three distinct categories of mutations were selected for study so that the blocking effects of SEA could be investigated with mutants displaying either enhanced or depressed I1 inactivation, as well as with a mutant displaying suppressed I2 inactivation (Matsuoka et al., 1997
; Dyck et al., 1998
; Maxwell et al., 1999
). The data obtained show clearly that SEA blocks NCX1.1 by mimicking or promoting entry of Na+-Ca2+ exchange molecules into the I1, but not the I2, inactive state.
| Materials and Methods |
|---|
|
|
|---|
20 to 35 ng cRNA, oocytes were maintained at 18°C for up to 7 days.
Preparation of Mutant Na+-Ca2+ Exchangers. Mutations were generated using the Sculptor in vitro mutagenesis kit (Amersham Biosciences) as described previously (Matsuoka et al., 1997
; Dyck et al., 1998
). Generally, two types of mutations were examined to determine the involvement of I1 and I2 inactivation in block of NCX1.1 currents by SEA. Single amino acid substitutions (F223E, K225Q, K229Q) and multiple amino acid deletions (
229-232,
680-685) were examined.
Electrophysiological Measurements. Electrophysiological measurements were obtained from days 3 to 7 after injection. Unidirectional outward (reverse) and inward (forward) Na+-Ca2+ exchange current measurements were obtained using the giant excised patch-clamp technique (Hilgemann, 1989
), as described previously (Dyck et al., 1998
). Before use in voltage-clamp experiments, the vitellin layer of the oocytes was removed by dissection. Oocytes were then placed in a solution containing 100 mM KOH, 100 mM MES, 20 mM HEPES, 5 mM EGTA, 5 to 10 mM MgCl2, pH 7.0, at RT with MES. Gigaohm seals were formed by suction, and inside-out membrane patches were excised by gentle movement of the patch pipette.
Solution changes were accomplished using a computer-controlled, 20-channel solution-switching device. For outward Na+-Ca2+ exchange current measurements, pipette (extracellular) solutions contained 100 mM NMG-MES, 30 mM HEPES, 30 mM TEA-OH, 16 mM sulfamic acid, 8.0 mM CaCO3, 6 mM KOH, 0.25 mM ouabain, 0.1 mM niflumic acid, and 0.1 mM flufenamic acid; pH adjusted to 7.0 at RT with MES. Outward currents were elicited by rapidly switching from Li+- to Na+-based bath solutions containing 100 mM [Na+ + Li+]-aspartate, 20 mM CsOH, 20 mM MOPS, 20 mM tetraethyl ammonium hydroxide, 10 mM EGTA, 0 to 9.91 mM CaCO3, and 1.0 to 1.5 mM Mg(OH)2; pH adjusted to 7.0 at 30°C with MES or LiOH. For inward Na+-Ca2+ exchange current measurements, the pipette (extracellular) solution contained 100 mM Na-MES, 20 mM CsOH, 20 mM tetraethyl ammonium hydroxide, 10 EGTA, 10 mM HEPES, 8 mM sulfamic acid, 4 mM Mg(OH)2, 0.25 mM ouabain, 0.1 mM niflumic acid, and 0.1 mM flufenamic acid; pH adjusted to 7.0 at RT with MES. Inward currents were activated by switching between Ca2+-free and Ca2+-containing, Li+-based bath solutions, described above. For brevity, only the Na+ and Ca2+ concentrations of experimental solutions are given under Results.
Axon Instruments (Union City, CA) hardware (Axopatch 200a) and software (Axotape) were used for data acquisition and analysis, and Origin software (OriginLab Corp, Northampton, MA) was used for curve-fitting and statistical analyses. Pooled data are presented as mean ± S.E.M. Two-tailed Student's t tests were used for comparison of unpaired data, and P < 0.05 was considered significant. Free Mg2+ and Ca2+ concentrations were calculated using MAXC software (Bers et al., 1994
). All experiments were conducted at 30°C.
SEA was dissolved in dimethyl sulfoxide as 20 to 40 mM stocks and diluted directly into bath solutions. After each drug concentration change, at least 32 s were allowed to lapse before re-examining current levels. The concentration of dimethyl sulfoxide never exceeded 0.075% and was without effect on inward or outward Na+-Ca2+ exchange current characteristics. SEA was generously provided by Taisho Pharmaceutical Company, Inc. (Tokyo, Japan).
| Results |
|---|
|
|
|---|
Figure 1, A and B, illustrates the basic characteristics of block by SEA of outward Na+-Ca2+ exchange currents mediated by NCX1.1. Addition of 0.1 µM SEA to the bath solution resulted in a significant inhibition of both peak and steady-state currents activated by 100 mM Na+i and 1 µM regulatory Ca2+i (Fig. 1A). Upon increasing the concentration of regulatory Ca2+i to 10 µM (Fig. 1B), there was a trend toward alleviation of block by SEA. This achieved statistical significance for peak currents [57 ± 6 (n = 12) versus 31 ± 8% inhibition (n = 8), p = 0.016] but not for steady-state currents [88 ± 5 (n = 10) versus 71 ± 7% inhibition (n = 8), p = 0.059] (Table 1). Previously reported IC50 values for inhibition of steady-state and peak outward currents by SEA were 23 and 78 nM, respectively, using the giant excised patch-clamp technique (Lee et al., 2003
).
|
|
To test the hypothesis that SEA stabilizes or facilitates entry of exchanger molecules into I1, we studied the effects of SEA on mutant exchangers with altered I1 and I2 inactivation profiles. The three distinct categories of mutant exchangers are shown in Fig. 2, A and B, and have been previously characterized (Matsuoka et al., 1997
). Group 1 mutants (F223E and K225Q) exhibit an accelerated rate of inactivation (
) of outward current and either an increase (F223E) or decrease (K225Q) in the extent of I1 inactivation, as gauged by the ratio of steady-state to peak current (Fss). A representative tracing is shown in Fig. 2A for F223E, which inactivates much faster and to a greater degree than wild-type NCX1.1. For group 2 mutations (K229Q and
229-232), the extent of I1 inactivation is greatly reduced and the residual inactivation is accelerated compared with NCX1.1 (see also Table 3). This is illustrated in Fig. 2A for
229-232, where outward currents essentially comprise a square waveform in the absence of Na+i-dependent inactivation. This behavior is analogous to that observed for outward Na+-Ca2+ exchange currents mediated by the wild-type exchanger in the presence of high concentrations of regulatory Ca2+. Under these conditions, I1 inactivation is greatly reduced, but the residual inactivation is accelerated (Hilgemann et al., 1992a
). Finally, the
680-685 mutation shown in Fig. 2B is characterized by a combination of greatly reduced or absent I1 and I2 inactivation. Figure 2B shows overlapping outward currents traces at 0, 1, and 10 µM regulatory Ca2+, illustrating the relative absence of both ionic regulatory processes. Note that the decrease in current magnitude at 10 µM regulatory Ca2+i primarily reflects competition between intracellular Na+ and Ca2+ for the transport sites of the exchanger. Pooled data for peak and steady-state outward current, Fss and
under control conditions are given in Tables 1, 2, 3.
|
|
|
The first set of experiments was conducted on mutants lacking Na+i-dependent inactivation. We reasoned that if SEA blocked Na+-Ca2+ exchange by interacting with the I1 inactivation process, then block should be suppressed in mutants lacking this inactivation. Indeed, Fig. 3A shows that block of outward current by 0.1 µM SEA is nearly absent in
229-232. This weak effect of SEA was observed at both high and low levels of regulatory Ca2+i (i.e., 1 and 10 µM). Data obtained from the K229Q mutant are illustrated in Fig. 3B. As shown in the left at 1 µM regulatory Ca2+i, SEA inhibited both peak and steady-state outward currents. The degree of block was intermediate compared with NCX1.1 and
229-232, particularly for peak current. When re-examined at a higher regulatory Ca2+i concentration (Fig. 3B, right), SEA also inhibited currents to an intermediate level between NCX1.1 and
229-232. Notably, however, there was a considerable relief of SEA inhibition of steady-state currents in the presence of high regulatory Ca2+ (Table 1).
|
The results obtained with these mutants are of particular interest, because SEA induces I1-like behavior for K229Q but is nearly without effect for the deletion mutant,
229-232. Both of these exchangers seem to lack a functional I1 inactivation mechanism in the absence of drug (Matsuoka et al., 1997
). Furthermore, for K229Q, a significant attenuation of steady-state current inhibition is observed after an increase in the concentration of regulatory Ca2+i from 1 to 10 µM, indicating that the I1-like inactivation induced by SEA behaves similarly to the native I1 inactivation process with respect to regulatory Ca2+i. Pooled data for inhibition of peak and steady-state current components by SEA in group 2 mutants are provided in Table 1.
Figure 4 shows the effect of 0.1 µM SEA on outward Na+-Ca2+ exchange currents for a mutant (F223E), where the rate and extent of I1 inactivation is enhanced. As demonstrated previously for this mutation of NCX1.1 (Matsuoka et al., 1997
), the decay of outward current is substantially accelerated (Fig. 4A), particularly at lower cytoplasmic Ca2+ concentrations (Table 1). Consistent with the hypothesis that SEA exerts its blocking actions by modulating I1 inactivation, inhibition of steady-state outward currents by SEA was considerably enhanced with F223E. Indeed, the extent of block was so pronounced that it was difficult to quantify the percentage inhibition and Fss, as steady-state currents were typically near or at baseline, as shown in Fig. 4, A and B. Peak outward currents remained less affected by SEA in the F223E mutant.
|
We examined the effects of SEA on a second mutant with enhanced I1 inactivation, K225Q (not shown). In this mutant, the degree of enhancement of I1 was considerably less, as shown in Tables 1, 2, 3. Here, the inhibitory effects of SEA on peak and steady-state outward currents were similar to wild-type at both 1 and 10 µM regulatory Ca2+ levels (Table 1). That is, unlike F223E, a clear facilitation of block was not observed for K225Q, possibly reflecting the more subtle nature of this mutation.
To gain further insight into the inhibitory effects of SEA, we evaluated its concentration dependence for inhibition of the
229-232 and F223E mutants. These particular mutants were selected for further investigation because they displayed the most prominent alterations in their responses to SEA compared with the wild-type exchanger. Pooled results are shown in Fig. 5. For
229-232, the inhibitory effects of SEA were evaluated on outward currents activated by 100 mM Na+i in the presence of 1 µM regulatory Ca2+. The IC50 values for inhibition of peak and steady-state currents were 0.32 ± 0.15 µM and 0.20 ± 0.05 µM (means ± S.E.M.), respectively. In general, these values are
4 to 10 times higher than those obtained for the wild-type exchanger under identical experimental conditions (Lee et al., 2003
). For the F223E mutant, the concentration dependence of SEA was examined on outward currents activated by 100 mM Na+i in the presence of 10 µM regulatory Ca2+. These experimental conditions were chosen to reduce the inhibitory potency of SEA and augment the magnitude of steady-state currents. In particular, the F223E mutant shows very small steady-state currents under control conditions, and SEA reduces these even further (Fig. 4). The limited signal-to-noise ratios for these types of measurements make IC50 measurements highly prone to error and variability. Nevertheless, within our limited ability to obtain such measurements, IC50 values of 65 ± 12 nM and 19 ± 7 nM (means ± S.E.M.) were obtained, for peak and steady-state currents, respectively, under conditions in which I1 inactivation was reduced by high regulatory Ca2+.
|
The effect of SEA on a mutant Na+-Ca2+ exchanger with suppressed Ca2+-dependent (I2) inactivation is shown in Fig. 6. The control data illustrate that steady-state outward currents mediated by
680-685 are relatively insensitive to elevation of cytosolic Ca2+ compared with NCX1.1 (e.g., Fig. 2B). Irrespective of this loss of Ca2+i-dependent regulation, the degree of block by SEA of both peak and steady-state current with
680-685 was similar to that observed with wild-type (Table 1). These data suggest that block of NCX1.1 by SEA may be largely independent of the I2 inactivation process.
|
Tables 2 and 3 show Fss and
data for NCX1.1 and all mutant exchangers in the absence and presence of 0.1 µM SEA. Fss is the ratio of steady-state to peak outward current and represents the fraction of active exchangers generating current at steady-state (Hilgemann et al., 1992b
). The measured rate constant for outward current inactivation,
, is thought to be related to the development of I1 as follows:
=
E3ni +
, where
is the rate constant for the transition of exchangers from the E3ni state into I1, E3ni is the fraction of three Na+-loaded exchangers oriented to the intracellular surface of the membrane, and
is the rate constant for recovery of exchangers from I1 to E3ni (Hilgemann et al., 1992b
; Omelchenko et al., 1998
). In general,
is a measure of the rate of I1 inactivation, whereas Fss is an index of the extent of I1 inactivation.
Compared with NCX1.1, Fss was increased for
229-232 and K229Q in the absence and presence of SEA, irrespective of the concentration of cytosolic Ca2+. This is consistent with the square-wave current waveform shown in Fig. 3 for
229-232, similar to that observed for wild-type NCX1.1 after removal of ionic regulation by limited proteolysis with
-chymotrypsin (Hilgemann, 1990
; Matsuoka et al., 1995
, 1997
; Hryshko, 2002
). Fss was reduced and
was increased for F223E under control conditions, and a further increase occurred in the presence of SEA. The effects of SEA on F223E and
229-232 are completely consistent with the notion that SEA exerts its inhibitory effects through interactions with the I1 inactivation process. For K229Q, SEA seemed to be able to induce an I1-like inactive state. However, the results with K225Q showed little difference from NCX1.1. We do not have a compelling explanation for this result, but we suggest the following: K225Q shows a modest increase in the rate of inactivation (
) but an actual decrease in the extent of inactivation (reflected by higher Fss values). This combination of opposing attributes might somehow protect K225Q from increased susceptibility to the inhibitory effects of SEA.
Inward Na+-Ca2+ Exchange. Inward Na+-Ca2+ exchange current (Ca2+ efflux mode) was initiated by switching from a Na+- and Ca2+-free bath solution to a solution containing variable amounts of Ca2+. The pipette (extracellular) solution contained 100 mM Na+ and was nominally Ca2+-free. Note that I1 inactivation is undetectable for inward currents as the concentration of Na+ in the bath solution is nominally zero. Inward Na+-Ca2+ exchange currents were measured in the presence of both low (3 µM) and high (10 µM) cytosolic Ca2+ concentrations. Figure 7A shows that inward currents mediated by NCX1.1 are relatively insensitive to block by SEA, compatible with the notion that SEA requires interaction with the Na+i-dependent inactivation process. The effect of SEA on inward exchange currents generated by
229-232 is shown in Fig. 7B, and a similar insensitivity was obtained. However, when F223E was examined (Fig. 7C), SEA produced a significant block of inward current. A similar tendency was observed with K225Q (Table 4). These results show that SEA is capable of exerting significant inhibitory effects on mutant exchangers with enhanced I1 inactivation, even under conditions in which this regulatory mechanism is typically minimal or absent. The greater block of inward currents by SEA for F223E compared with K225Q corresponds to the results obtained for outward currents.
|
|
| Discussion |
|---|
|
|
|---|
229-232, K229Q) compared with the wild-type exchanger. This was particularly evident for the deletion mutant,
229-232, whereas SEA seemed to induce an I1-like inactivation in the point mutant, K229Q. For the two mutants with accelerated I1 inactivation (F223E, K225Q), block of outward current by SEA was facilitated only for the mutant with increased inactivation (F223E) and was without significant effect on the point mutation (K225Q). Finally,
680-685, which lacks Ca2+i-dependent (I2) inactivation, behaved similarly to wild-type with respect to inhibition by SEA, suggesting that I2 inactivation may not play a major role in the inhibitory action of this agent. Our data provide further evidence supporting a prominent role for Na+i-dependent inactivation in the inhibitory action of SEA.
Role of I1 Inactivation in SEA Inhibition. Ionic regulation of NCX1.1 involves protein domains within the large intracellular loop of the exchanger between transmembrane segments 5 and 6 (Philipson and Nicoll, 2000
; Hryshko, 2002
; Quednau et al., 2004
). The so-called XIP region, which comprises amino acids 219 to 238, seems to be involved in Na+i-dependent inactivation because mutations in this region affect both the rate and degree of inactivation (Matsuoka et al., 1997
). Similar data have been reported for CALX1.1 when mutations were made at the analogous positions of its amino acid sequence (Dyck et al., 1998
). Given our previous observations (Lee et al., 2003
) of 1) an apparent transport mode-specific block of NCX1.1 exchangers by SEA, 2) a substantial relief of inhibition in de-regulated exchangers after
-chymotrypsin treatment, 3) a reduction of block after elevation of cytosolic Ca2+ concentration, which typically relieves I1 inactivation, and 4) a prominent intracellular Na+i-dependence for the inhibitory potency of SEA, we postulated that inhibition of NCX1.1 by SEA was state-dependent and that SEA stabilized or promoted entry of exchange molecules into the I1 inactive state. Several lines of evidence in the present work directly support this hypothesis.
The strongest evidence favoring a state-dependent blocking mechanism by SEA is the data obtained with
229-232 and F223E. The ability of SEA to inhibit outward or inward Na+-Ca2+ exchange currents was greatly reduced with
229-232, a mutant in which I1 inactivation seems to be absent (Matsuoka et al., 1997
). Similarly, the degree of inhibition was increased for F223E, a mutant showing an increase of
2-fold in the rate and extent of I1 inactivation compared with NCX1.1. Indeed, exposure of F223E to SEA resulted in a nearly complete inhibition of steady-state outward current in the presence of 1 µM Ca2+i. Notably, when complete concentration dependence profiles were obtained for these two mutants, a substantial decrease in the apparent IC50 was obtained for
229-232 whereas only a slight increase (not significant) in potency was observed for F223E compared with the wild-type exchanger (Lee et al., 2003
). However, the results for F223E were obtained under conditions in which inhibitory potency was reduced (i.e., at high regulatory Ca2+) to obtain measurable signals, making such direct comparisons difficult. Moreover, analysis of this type does not permit any conclusions to be derived regarding the site of action of SEA because the apparent IC50 values obtained do not necessarily provide information on the drug binding affinity. Specifically, our results indicate that I1 inactivation is involved in the inhibitory effects of SEA. Whether this relationship involves direct interactions with the XIP region of the exchange molecule or occurs via long range interactions and/or stabilization of distinct exchanger states cannot be determined by such analyses.
Interestingly, an intermediate response was observed for a second mutant lacking I1 inactivation, K229Q. No obvious I1 inactivation was observed for K229Q under control conditions. However, SEA clearly induced an I1-like inactivation of outward current for this mutant. Moreover, as with the native I1 inactivation process, increasing regulatory Ca2+ substantially alleviated the extent of this inhibition. We speculate that the subtler point mutation retains the capability of transitioning from the E3ni state into the I1 inactive state, although the I1 state may be very unstable in this mutant. In the current study, SEA seemed to stabilize the I1 state. In contrast, with the larger deletion mutant (
229-232), we postulate that the I1 state is nearly unable to form and therefore SEA loses most of its effectiveness. We also observed that treatment of patches with
-chymotrypsin to remove ionic regulation greatly reduced the inhibitory effects of SEA for wild-type NCX1.1 (Lee et al., 2003
) and for all mutants investigated here (data not shown).
SEA produced a substantial inhibition of inward currents with F223E, even though I1 inactivation is not normally observed for these currents. Although we cannot fully account for this behavior, a plausible explanation is that the I1 state is clearly facilitated in F223E, reflected by a greatly reduced steady-state current and an increased rate of current inactivation. Typically, the I1 state, which originates from the E3ni transport state of the exchanger, has a far greater likelihood of developing for outward currents because cytoplasmic Na+ is high. Because the subsequent occlusion and reorientation of exchanger binding sites to the extracellular surface is rate-limiting (Hilgemann et al., 1991
), exchangers can accumulate in E3ni from where they partition into I1 or undergo ion translocation. In contrast, for inward currents, the only source of E3ni is from exchangers reorienting from the extracellular side with bound Na+ (i.e., from the E3no state). Here, unbinding of Na+ is the most favored transition because there is no Na+ on the intracellular surface. Because exchangers are far less likely to accumulate in E3ni during inward currents, I1 inactivation is normally not observed.
Based on the foregoing, SEA is far more effective at inhibiting outward currents compared with inward exchange currents. However, in the case of F223E, the I1 state is considerably augmented. Possibly, this enhancement may be sufficient such that I1 can also occur during inward current, albeit to a lesser extent. If SEA further stabilized this small population of I1 inactivated exchangers, its inhibitory effects could be explained. The somewhat diminished effects of SEA on K225Q inward currents offer general support for this possibility. Clearly, other potential explanations exist, although we presently favor the above, based on the similarities between K225Q and F223E.
Notably, the inhibitory actions of SEA were also apparent for peak outward Na+-Ca2+ exchange currents, albeit to a lesser extent than that observed for steady-state currents. Therefore, it seems reasonable to postulate that the inhibitory effects of SEA include additional actions beyond that of facilitating I1 inactivation. In general, peak outward current magnitude is thought to reflect exchange activity before the development of I1 inactivation. However, caution is also required for this interpretation, because the magnitude of peak current reflects the balance between its rate of development (limited largely by solution switching time) opposed by the rate at which I1 inactivation develops. Thus, under conditions at which I1 inactivation is greatly facilitated, either by drugs and/or mutagenesis, it remains possible that this process could influence the magnitude of peak currents. At present, we lack the temporal resolution to distinguish between these two possibilities. The greatly diminished effects of SEA for inward currents at which I1 inactivation is absent and the coincident changes in inhibitory potency with the preponderance of the I1 inactive state do not exclude either possibility.
Given the Ca2+i-dependence of both I1 and I2 inactivation, it is also possible that SEA exerts some of its blocking action via modulation of I2 inactivation. We addressed this possibility by investigating the effects of SEA on a deletion mutant,
680-685, where I2 inactivation is significantly reduced (Maxwell et al., 1999
). Indeed, block of peak and steady-state outward currents by SEA for the
680-685 mutant was very similar to that of wild-type NCX1.1. However, involvement of I2 inactivation cannot be completely ruled out, because previous work has shown that both I1 and I2 inactivation are altered with
680-685 (Maxwell et al., 1999
).
It is interesting to compare our results with those previously obtained with KB-R7943, a less potent and less selective Na+-Ca2+ exchange inhibitor first described in 1996 (Iwamoto et al., 1996
; Watano et al., 1996
). Using a variety of techniques, KB-R7943 was also found to exhibit transport mode selectivity, whereby inhibition of the reverse transport mode was favored (Iwamoto et al., 1996
; Watano et al., 1996
; Elias et al., 2001
; but see Kimura et al., 1999
). The site of action of KB-R7943 remains unknown, although amino acid residues (particularly Gly833) within the
-2 repeat region of the exchanger have been reported to markedly affect drug sensitivity (Iwamoto et al., 2001
). These authors have suggested that the site of KB-R7943 is on the external side of intact cells, because drug sensitivity was greatest when applied extracellularly, whereas drug applied intracellularly was largely without effect (Iwamoto et al., 2001
). At present, the site of action of SEA must be considered unknown. Based on our current study and our previous work with KB-R7943, we find that intracellular application of these agents produces profound inhibitory effects on the reverse transport mode of exchange current. Moreover, the inhibitory potencies and characteristics are nearly identical to those reported in intact cells. Although our experimental results favor an intracellular or intramembrane site of action, we cannot exclude the possibility of an external site of action. Finally, the identified interaction between SEA and the intrinsic I1 inactivation mechanism does not imply a direct physical interaction with the XIP domain of the exchanger.
In summary, our data provide a plausible explanation for the apparent mode selectivity of SEA. That is, the major effect of SEA is to enhance Na+i-dependent inactivation. The effectiveness of inhibition of Na+-Ca2+ exchange current by SEA generally follows the prevalence of the I1 inactive state, whether this is manipulated by mutagenesis, as in this study, or by altering the ionic transport conditions (Lee et al., 2003
). Recognition of this molecular mechanism of action of SEA should prove beneficial toward facilitating the development and pharmacology of Na+-Ca2+ exchange inhibitors. Moreover, the enhanced inhibitory potency of SEA under conditions of elevated intracellular Na+ seems to be an ideal attribute when considering its potential utility against ischemia-reperfusion injury.
| Footnotes |
|---|
ABBREVIATIONS: SEA, SEA0400 (2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline); CALX1.1, Na+-Ca2+ exchanger from Drosophila melanogaster;I1, Na+-dependent inactivation; I2, Ca2+-dependent inactivation; NCX1.1, wild-type cardiac sarcolemmal Na+-Ca2+ exchanger; RT, room temperature; MES, 2-(N-morpholino)ethanesulfonic acid; MOPS, 3-(N-morpholino)propanesulfonic acid; KB-R7943, 2-[2-[4-(4-nitrobenzyloxy)phenyl]ethyl]isothiourea.
Address correspondence to: Dr. Larry V. Hryshko, Institute of Cardiovascular Sciences, University of Manitoba Faculty of Medicine, St. Boniface Research Centre, 351 Tache Avenue, Winnipeg, Manitoba, Canada, R2H 2A6. E-mail: lhryshko{at}sbrc.ca
| References |
|---|
|
|
|---|
Dyck C, Maxwell K, Buchko J, Trac M, Omelchenko A, Hnatowich M, and Hryshko LV (1998) Structure-function analysis of CALX1.1, a Na+-Ca2+ exchanger from Drosophila. Mutagenesis of ionic regulatory sites. J Biol Chem 273: 12981-12987.
Elias CL, Lukas A, Shurraw S, Scott J, Omelchenko A, Gross GJ, Hnatowich M, and Hryshko LV (2001) Inhibition of Na+/Ca2+ exchange by KB-R7943: Transport mode selectivity and antiarrhythmic consequences. Am J Physiol 281: H1334-H1345.
Hilgemann DW (1989) Giant excised cardiac sarcolemmal membrane patches: sodium and sodium-calcium exchange currents. Pflugers Arch 415: 247-249.[CrossRef][Medline]
Hilgemann DW (1990) Regulation and deregulation of cardiac Na+-Ca2+ exchange in giant excised sarcolemmal membrane patches. Nature (Lond) 344: 242-245.[CrossRef][Medline]
Hilgemann DW, Collins A, and Matsuoka S (1992a) Steady-state and dynamic properties of cardiac sodium-calcium exchange. Secondary modulation by cytoplasmic calcium and ATP. J Gen Physiol 100: 933-961.
Hilgemann DW, Matsuoka S, Nagel GA, and Collins A (1992b) Steady-state and dynamic properties of cardiac sodium-calcium exchange. Sodium-dependent inactivation. J Gen Physiol 100: 905-932.
Hilgemann DW, Nicoll DA, and Philipson KD (1991) Charge movement during Na+ translocation by native and cloned cardiac Na+/Ca2+ exchanger. Nature (Lond) 352: 715-718.[CrossRef][Medline]
Hryshko LV (2002) The cardiac Na+-Ca2+ exchanger, in Handbook of Physiology. Section 2: The Cardiovascular System. Vol. 1: The Heart (Page E, Fozzard HA, and Solaro RJ eds) pp 388-419, Oxford University Press, Oxford.
Iwamoto T, Kita S, Uehara A, Inoue Y, Taniguchi Y, Imanaga I, and Shigekawa M (2001) Structural domains influencing sensitivity to isothiourea derivative inhibitor KB-R7943 in cardiac Na+/Ca2+ exchanger. Mol Pharmacol 59: 524-531.
Iwamoto T, Watano T, and Shigekawa M (1996) A novel isothiourea derivative selectively inhibits the reverse mode of Na+/Ca2+ exchange in cells expressing NCX1. J Biol Chem 271: 22391-22397.
Kimura J, Watano T, Kawahara M, Sakai E, and Yatabe J (1999) Direction-independent block of bi-directional Na+/Ca2+ exchange current by KB-R7943 in guinea-pig cardiac myocytes. Br J Pharmacol 128: 969-974.[CrossRef][Medline]
Lee C, Le HD, Isaac MR, Omelchenko A, Hnatowich M, Matsuda T, Baba A, Takahashi K, and Hryshko LV (2003) Inhibitory effects of SEA0400 on the cardiac Na-Ca exchanger, NCX1.1 (Abstract). Biophys J 84: 190a.
Levitsky DO, Nicoll DA, and Philipson KD (1994) Identification of the high affinity Ca2+-binding domain of the cardiac Na+-Ca2+ exchanger. J Biol Chem 269: 22847-22852.
Matsuda T, Arakawa N, Takuma K, Kishida Y, Kawasaki Y, Sakaue M, Takahashi K, Takahashi T, Suzuki T, Ota T, et al. (2001) SEA0400, a novel and selective inhibitor of the Na+-Ca2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. J Pharmacol Exp Ther 298: 249-256.
Matsuoka S, Nicoll DA, He Z, and Philipson KD (1997) Regulation of cardiac Na+-Ca2+ exchanger by the endogenous XIP region. J Gen Physiol 109: 273-286.
Matsuoka S, Nicoll DA, Hryshko LV, Levitsky DO, Weiss JN, and Philipson KD (1995) Regulation of the cardiac Na+-Ca2+ exchanger by Ca2+. Mutational analysis of the Ca2+-binding domain. J Gen Physiol 105: 403-420.
Maxwell K, Scott J, Omelchenko A, Lukas A, Lu L, Lu Y, Hnatowich M, Philipson KD, and Hryshko LV (1999) Functional role of ionic regulation of Na+/Ca2+ exchange assessed in transgenic mouse hearts. Am J Physiol 277: H2212-H2221.
Omelchenko A, Dyck C, Hnatowich M, Buchko J, Nicoll DA, Philipson KD, and Hryshko LV (1998) Functional differences in ionic regulation between alternatively spliced isoforms of the Na+-Ca2+ exchanger from Drosophila melanogaster. J Gen Physiol 111: 691-702.
Philipson KD and Nicoll DA (2000) Sodium-calcium exchange: a molecular perspective. Annu Rev Physiol 62: 111-133.[CrossRef][Medline]
Quednau BD, Nicoll DA, and Philipson KD (2004) The sodium/calcium exchanger family-SLC8. Pflueg Arch Eur J Physiol (in press).
Tanaka H, Nishimaru K, Aikawa T, Hirayama W, Tanaka Y, and Shigenobu K (2002) Effect of SEA0400, a novel inhibitor of sodium-calcium exchanger, on myocardial ionic currents. Br J Pharmacol 135: 1096-1100.[CrossRef][Medline]
Watano T, Kimura J, Morita T, and Nakanishi H (1996) A novel antagonist, no. 7943, of the Na+/Ca2+ exchange current in guinea-pig cardiac ventricular cells. Br J Pharmacol 119: 555-563.[Medline]
This article has been cited by other articles:
![]() |
P. Birinyi, A. Toth, I. Jona, K. Acsai, J. Almassy, N. Nagy, J. Prorok, I. Gherasim, Z. Papp, Z. Hertelendi, et al. The Na+/Ca2+ exchange blocker SEA0400 fails to enhance cytosolic Ca2+ transient and contractility in canine ventricular cardiomyocytes Cardiovasc Res, June 1, 2008; 78(3): 476 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iwamoto and S. Kita YM-244769, a Novel Na+/Ca2+ Exchange Inhibitor That Preferentially Inhibits NCX3, Efficiently Protects against Hypoxia/Reoxygenation-Induced SH-SY5Y Neuronal Cell Damage Mol. Pharmacol., December 1, 2006; 70(6): 2075 - 2083. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iwamoto Vascular Na+/Ca2+ exchanger: implications for the pathogenesis and therapy of salt-dependent hypertension Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R536 - R545. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dipolo and L. Beauge Sodium/Calcium Exchanger: Influence of Metabolic Regulation on Ion Carrier Interactions Physiol Rev, January 1, 2006; 86(1): 155 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Beauge and R. DiPolo SEA-0400, a potent inhibitor of the Na+/Ca2+ exchanger, as a tool to study exchanger ionic and metabolic regulation Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1374 - C1380. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lee, N. S. Visen, N. S. Dhalla, H. D. Le, M. Isaac, P. Choptiany, G. Gross, A. Omelchenko, T. Matsuda, A. Baba, et al. Inhibitory Profile of SEA0400 [2-[4-[(2,5-Difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline] Assessed on the Cardiac Na+-Ca2+ Exchanger, NCX1.1 J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 748 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Akabas Na+/Ca2+ Exchange Inhibitors: Potential Drugs to Mitigate the Severity of Ischemic Injury Mol. Pharmacol., July 1, 2004; 66(1): 8 - 10. [Full Text] [PDF] |
||||
![]() |
T. Iwamoto, Y. Inoue, K. Ito, T. Sakaue, S. Kita, and T. Katsuragi The Exchanger Inhibitory Peptide Region-Dependent Inhibition of Na+/Ca2+ Exchange by SN-6 [2-[4-(4-Nitrobenzyloxy)benzyl]thiazolidine-4-carboxylic Acid Ethyl Ester], a Novel Benzyloxyphenyl Derivative Mol. Pharmacol., July 1, 2004; 66(1): 45 - 55. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||